For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
Spleen volume was linked with an increased risk of IBD in a Mendelian randomization study. (Scientific Reports) A dual ...
A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that ...
A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...
For more than a decade, Michelle Hobson endured extreme fatigue, excruciating abdominal pain, and repeated hospital visits.
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...
Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then ...